{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:06:55Z","timestamp":1792598815578,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00415-018-9110-6","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T06:06:06Z","timestamp":1543471566000},"page":"268-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["POEMS syndrome: clinical update"],"prefix":"10.1007","volume":"266","author":[{"given":"Rachel","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"9110_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ajh.24802","volume":"92","author":"A Dispenzieri","year":"2017","unstructured":"Dispenzieri A (2017) POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management. Am J Hematol 92:814\u2013829","journal-title":"Am J Hematol"},{"key":"9110_CR2","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","volume":"101","author":"A Dispenzieri","year":"2003","unstructured":"Dispenzieri A et al (2003) POEMS syndrome: Definitions and long-term outcome. Blood 101:2496\u20132506","journal-title":"Blood"},{"key":"9110_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","volume":"83","author":"S Nasu","year":"2012","unstructured":"Nasu S et al (2012) Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 83:476\u2013479","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/jnnp.2007.135681","volume":"79","author":"H Koike","year":"2008","unstructured":"Koike H et al (2008) Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry 79:1171\u20131179","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.clinph.2004.11.011","volume":"116","author":"JH Min","year":"2005","unstructured":"Min JH, Hong YH, Lee K (2005) W. Electrophysiological features of patients with POEMS syndrome. Clin Neurophysiol 116:965\u2013968","journal-title":"Clin Neurophysiol"},{"key":"9110_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jocn.2010.07.124","volume":"18","author":"GB Kulkarni","year":"2011","unstructured":"Kulkarni GB et al (2011) Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. J Clin Neurosci 18:356\u2013360","journal-title":"J Clin Neurosci"},{"key":"9110_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mus.24267","volume":"51","author":"M Liu","year":"2015","unstructured":"Liu M et al (2015) Motor nerve conduction study and muscle strength in newly diagnosed poems syndrome. Muscle Nerve 51:19\u201323","journal-title":"Muscle Nerve"},{"key":"9110_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.10182","volume":"26","author":"JY Sung","year":"2002","unstructured":"Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T (2002) Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 26:189\u2013193","journal-title":"Muscle Nerve"},{"key":"9110_CR9","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1002\/mus.25684","volume":"56","author":"H Kim","year":"2017","unstructured":"Kim H et al (2017) Electrophysiologic features of POEMS syndrome compared with MGUS-related neuropathy. Muscle Nerve 56:E73\u2013E77","journal-title":"Muscle Nerve"},{"key":"9110_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01913120309941","volume":"27","author":"C Vital","year":"2003","unstructured":"Vital C et al (2003) Uncompacted myelin lamellae in peripheral nerve biopsy. Ultrastruct Pathol 27:1\u20135","journal-title":"Ultrastruct Pathol"},{"key":"9110_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1529-8027.2003.03019.x","volume":"8","author":"C Vital","year":"2003","unstructured":"Vital C et al (2003) Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst 8:136\u2013144","journal-title":"J Peripher Nerv Syst"},{"key":"9110_CR12","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1182\/blood-2010-11-316935","volume":"117","author":"LN Dao","year":"2011","unstructured":"Dao LN et al (2011) Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood 117:6438\u20136444","journal-title":"Blood"},{"key":"9110_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.blre.2017.11.005","volume":"32","author":"M Haap","year":"2018","unstructured":"Haap M, Wiefels J, Horger M, Hoyer A, M\u00fcssig K (2018) Clinical, laboratory and imaging findings in Castleman\u2019s disease\u2014the subtype decides. Blood Rev 32:225\u2013234","journal-title":"Blood Rev"},{"key":"9110_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1212\/WNL.0000000000003405","volume":"87","author":"E Naddaf","year":"2016","unstructured":"Naddaf E, Dispenzieri A, Mandrekar J, Mauermann ML (2016) Clinical spectrum of Castleman disease\u2014associated neuropathy. Neurology 87:2457\u20132462","journal-title":"Neurology"},{"key":"9110_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.23291","volume":"87","author":"A Dispenzieri","year":"2012","unstructured":"Dispenzieri A et al (2012) The clinical spectrum of Castleman\u2019s disease. Am J Hematol 87:997\u20131002","journal-title":"Am J Hematol"},{"key":"9110_CR16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2169\/internalmedicine.50.5263","volume":"50","author":"K Shibuya","year":"2011","unstructured":"Shibuya K et al (2011) Detection of bone lesions by CT in POEMS syndrome. Intern Med 50:1393\u20131396","journal-title":"Intern Med"},{"key":"9110_CR17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2967\/jnumed.115.160507","volume":"56","author":"Q Pan","year":"2015","unstructured":"Pan Q, Li J, Li F, Zhou D, Zhu Z (2015) Characterizing POEMS Syndrome with 18F-FDG PET\/CT. J Nucl Med 56:1334\u20131337","journal-title":"J Nucl Med"},{"key":"9110_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2015-009157","volume":"5","author":"S Misawa","year":"2015","unstructured":"Misawa S et al (2015) Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: Retrospective cohort study. BMJ Open 5:1\u20137","journal-title":"BMJ Open"},{"key":"9110_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/0284185114564614","volume":"57","author":"X Shi","year":"2016","unstructured":"Shi X et al (2016) CT characteristics in 24 patients with POEMS syndrome. Acta radiol 57:51\u201357","journal-title":"Acta radiol"},{"key":"9110_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.4065\/82.7.836","volume":"82","author":"GY Gandhi","year":"2007","unstructured":"Gandhi GY et al (2007) Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin. Proc 82:836\u2013842","journal-title":"Mayo Clin. Proc"},{"key":"9110_CR21","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3109\/10428190903324236","volume":"50","author":"X-Y Dun","year":"2009","unstructured":"Dun X-Y, Zhou F, Xi H, Yuan Z-G, Hou J (2009) Thyroid function and its clinical significance in POEMS syndrome. Leuk Lymphoma 50:2013\u20132016","journal-title":"Leuk Lymphoma"},{"key":"9110_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ando.2017.01.004","volume":"78","author":"M Marchand","year":"2017","unstructured":"Marchand M, Haroche J, Touraine P, Courtillot C (2017) Atteintes endocriniennes dans le POEMS syndrome: cons\u00e9quences incomprises d\u2019un syndrome paran\u00e9oplasique rare. Ann Endocrinol (Paris) 78:190\u2013194","journal-title":"Ann Endocrinol (Paris)"},{"key":"9110_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1365-4632.2012.05648.x","volume":"52","author":"RYN Miest","year":"2013","unstructured":"Miest RYN, Comfere NI, Dispenzieri A, Lohse CM, el-Azhary RA (2013) Cutaneous manifestations in patients with POEMS syndrome. Int J Dermatol 52:1349\u20131356","journal-title":"Int J Dermatol"},{"key":"9110_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archdermatol.2010.100","volume":"146","author":"S Barete","year":"2010","unstructured":"Barete S et al (2010) Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation. Arch Dermatol 146:615\u2013623","journal-title":"Arch Dermatol"},{"key":"9110_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0421-3","volume":"11","author":"N Araki","year":"2016","unstructured":"Araki N et al (2016) POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification Rare skin diseases. Orphanet J Rare Dis 11:1\u20137","journal-title":"Orphanet J Rare Dis"},{"key":"9110_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ophtha.2010.08.013","volume":"118","author":"M Kaushik","year":"2011","unstructured":"Kaushik M, Pulido JS, Abreu R, Amselem L, Dispenzieri A (2011) Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Ophthalmology 118:778\u2013782","journal-title":"Ophthalmology"},{"key":"9110_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bjophthalmol-2015-307068","volume":"100","author":"H Yokouchi","year":"2016","unstructured":"Yokouchi H et al (2016) Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol 100:897\u2013901","journal-title":"Br J Ophthalmol"},{"key":"9110_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3324\/haematol.2012.073031","volume":"98","author":"J Li","year":"2013","unstructured":"Li J et al (2013) Pulmonary hypertension in POEMS syndrome. Haematologica 98:393\u2013398","journal-title":"Haematologica"},{"key":"9110_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1164\/ajrccm.157.3.9707095","volume":"157","author":"P Lesprit","year":"1998","unstructured":"Lesprit P et al (1998) Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 157:907\u2013911","journal-title":"Am J Respir Crit Care Med"},{"key":"9110_CR30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1378\/chest.07-1800","volume":"133","author":"JS Allam","year":"2008","unstructured":"Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A (2008) Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Chest 133:969\u2013974","journal-title":"Chest"},{"key":"9110_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/jnnp-2011-300047","volume":"83","author":"C Briani","year":"2012","unstructured":"Briani C et al (2012) Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. J Neurol Neurosurg Psychiatry 83:33\u201337","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1212\/WNL.0b013e3181bd136b","volume":"73","author":"SA Dupont","year":"2009","unstructured":"Dupont SA, Dispenzieri A, Mauermann ML, Rabinstein AA, Brown RD (2009) Cerebral infarction in POEMS syndrome: Incidence, risk factors, and imaging characteristics. Neurology 73:1308\u20131312","journal-title":"Neurology"},{"key":"9110_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ndt\/gfw165.07","volume":"31","author":"W Ye","year":"2016","unstructured":"Ye W et al (2016) Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: Incidence, treatment and outcome. Nephrol Dial Transpl 31:275\u2013283","journal-title":"Nephrol Dial Transpl"},{"key":"9110_CR34","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/ndt\/14.10.2370","volume":"14","author":"Y Nakamoto","year":"1999","unstructured":"Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB (1999) A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transpl 14:2370\u20132386","journal-title":"Nephrol Dial Transpl"},{"key":"9110_CR35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jnnp-2017-316427","volume":"88","author":"S Kuwabara","year":"2017","unstructured":"Kuwabara S et al (2017) Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: A multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry 88:832\u2013838","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-016-0389-1","volume":"4","author":"EA Piccione","year":"2016","unstructured":"Piccione EA et al (2016) Nerve pathologic features differentiate POEMS syndrome from CIDP. Acta Neuropathol Commun 4:116","journal-title":"Acta Neuropathol Commun"},{"key":"9110_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004773","author":"E Burnor","year":"2017","unstructured":"Burnor E et al (2017) Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004773","journal-title":"Neurology"},{"key":"9110_CR38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","volume":"92","author":"HM Chaudhry","year":"2017","unstructured":"Chaudhry HM, Mauermann ML, Rajkumar SV (2017) Monoclonal gammopathy\u2013associated peripheral neuropathy: diagnosis and management. Mayo Clin. Proc 92:838\u2013850","journal-title":"Mayo Clin. Proc"},{"key":"9110_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","volume":"89","author":"J Svahn","year":"2018","unstructured":"Svahn J et al (2018) Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. J Neurol Neurosurg Psychiatry 89:499\u2013505","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ajh.24557","volume":"92","author":"MA Gertz","year":"2017","unstructured":"Gertz MA (2017) Waldenstr\u00f6m macroglobulinemia 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92:209\u2013217","journal-title":"Am J Hematol"},{"key":"9110_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/jnnp.2005.071175","volume":"77","author":"T Levine","year":"2006","unstructured":"Levine T et al (2006) Peripheral neuropathies in Waldenstr\u00f6m\u2019s macroglobulinaemia. J Neurol Neurosurg Psychiatry 77:224\u2013228","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S0317167100011483","volume":"38","author":"CJ Klein","year":"2011","unstructured":"Klein CJ et al (2011) The Neuropathies of Waldenstr\u00f6m\u2019s Macroglobulinemia (WM) and IgM-MGUS. Can J Neurol Sci 38:289\u2013295","journal-title":"Can J Neurol Sci"},{"key":"9110_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/bjh.12760","volume":"165","author":"RG Owen","year":"2014","unstructured":"Owen RG et al (2014) Guidelines on the diagnosis and management of Waldenstr\u00f6m macroglobulinaemia. Br J Haematol 165:316\u2013333","journal-title":"Br J Haematol"},{"key":"9110_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ajh.24402","volume":"91","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV (2016) Multiple myeloma 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91:719\u2013734","journal-title":"Am J Hematol"},{"key":"9110_CR45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ajh.24433","volume":"91","author":"MA Gertz","year":"2016","unstructured":"Gertz MA (2016) Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment. Am J Hematol 91:947\u2013956","journal-title":"Am J Hematol"},{"key":"9110_CR46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1468-1331.2010.03215.x","volume":"18","author":"M Matsuda","year":"2011","unstructured":"Matsuda M et al (2011) Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. Eur J Neurol 18:604\u2013610","journal-title":"Eur J Neurol"},{"key":"9110_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1212\/WNL.0b013e3181d55f4d","volume":"74","author":"D Dingli","year":"2010","unstructured":"Dingli D et al (2010) Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis. Neurology 74:913\u2013918","journal-title":"Neurology"},{"key":"9110_CR48","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","volume":"124","author":"HJ Willison","year":"2001","unstructured":"Willison HJ et al (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124:1968\u20131977","journal-title":"Brain"},{"key":"9110_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/mus.23897","volume":"48","author":"PA McKelvie","year":"2013","unstructured":"McKelvie PA, Gates PC, Day T (2013) Canomad report of a case with a 40-year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade? Muscle Nerve 48:599\u2013603","journal-title":"Muscle Nerve"},{"key":"9110_CR50","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.22167","volume":"44","author":"C Kam","year":"2011","unstructured":"Kam C et al (2011) CANOMAD presenting without ophthalmoplegia and responding to intravenous immunoglobulin. Muscle Nerve 44:829\u2013833","journal-title":"Muscle Nerve"},{"key":"9110_CR51","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1474-4422(16)30157-0","volume":"15","author":"S Misawa","year":"2016","unstructured":"Misawa S et al (2016) Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 15:1129\u20131137","journal-title":"Lancet Neurol"},{"key":"9110_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006828.pub3","author":"S Kuwabara","year":"2012","unstructured":"Kuwabara S, Dispenzieri A, Arimura K, Misawa S, Nakaseko C (2012) Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006828.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"9110_CR53","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1182\/blood-2012-03-378992","volume":"119","author":"A Dispenzieri","year":"2012","unstructured":"Dispenzieri A (2012) How I treat POEMS syndrome. Blood 119:5650\u20135658","journal-title":"Blood"},{"key":"9110_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","volume":"122","author":"MS Humeniuk","year":"2013","unstructured":"Humeniuk MS et al (2013) Outcomes of patients with POEMS syndrome treated initially with radiation. Blood 122:68\u201373","journal-title":"Blood"},{"key":"9110_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13014-014-0265-8","volume":"9","author":"Y-G Suh","year":"2014","unstructured":"Suh Y-G et al (2014) The role of radiotherapy in the management of POEMS syndrome. Radiat Oncol 9:265","journal-title":"Radiat Oncol"},{"key":"9110_CR56","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","volume":"117","author":"J Li","year":"2011","unstructured":"Li J et al (2011) Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 117:6445\u20136449","journal-title":"Blood"},{"key":"9110_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood-2012-04-423178","volume":"120","author":"A D\u2019Souza","year":"2012","unstructured":"D\u2019Souza A et al (2012) Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (Osteosclerotic myeloma): a single-center experience. Blood 120:56\u201362","journal-title":"Blood"},{"key":"9110_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3324\/haematol.2016.148460","volume":"102","author":"G Cook","year":"2017","unstructured":"Cook G et al (2017) High-dose therapy and autologous stem cell transplantation in patients with poems syndrome: a retrospective study of the plasma cell disorder sub-committee of the chronic malignancy working party of the European society for blood & marrow transplantation. Haematologica 102:160\u2013167","journal-title":"Haematologica"},{"key":"9110_CR59","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1212\/WNL.0000000000001565","volume":"84","author":"C Karam","year":"2015","unstructured":"Karam C et al (2015) Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome. Neurology 84:1981\u20131987","journal-title":"Neurology"},{"key":"9110_CR60","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ajh.25100","volume":"93","author":"J Li","year":"2018","unstructured":"Li J et al (2018) A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol 93:803\u2013809","journal-title":"Am J Hematol"},{"key":"9110_CR61","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bjh.14966","volume":"179","author":"A Nozza","year":"2017","unstructured":"Nozza A et al (2017) Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial. Br J Haematol 179:748\u2013755","journal-title":"Br J Haematol"},{"key":"9110_CR62","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3109\/10428194.2014.974595","volume":"56","author":"E Lestang","year":"2015","unstructured":"Lestang E et al (2015) Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients. Leuk Lymphoma 56:1895\u20131896","journal-title":"Leuk Lymphoma"},{"key":"9110_CR63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/ejh.12492","volume":"95","author":"Q-Q Cai","year":"2015","unstructured":"Cai Q-Q et al (2015) Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome. Eur J Haematol 95:325\u2013330","journal-title":"Eur J Haematol"},{"key":"9110_CR64","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ajh.23374","volume":"88","author":"B Royer","year":"2013","unstructured":"Royer B et al (2013) Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients. Am J Hematol 88:207\u2013212","journal-title":"Am J Hematol"},{"key":"9110_CR65","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3109\/10428194.2013.869329","volume":"55","author":"F Zagouri","year":"2014","unstructured":"Zagouri F et al (2014) Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis. Leuk Lymphoma 55:2018\u20132023","journal-title":"Leuk Lymphoma"},{"key":"9110_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bjh.14497","volume":"181","author":"H He","year":"2018","unstructured":"He H, Fu W, Du J, Jiang H, Hou J (2018) Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen. Br J Haematol 181:126\u2013128","journal-title":"Br J Haematol"},{"key":"9110_CR67","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/jnnp-2012-304874","volume":"84","author":"Y Sekiguchi","year":"2013","unstructured":"Sekiguchi Y et al (2013) Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. J Neurol Neurosurg Psychiatry 84:1346\u20131348","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9110_CR68","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1182\/blood-2005-12-5045","volume":"107","author":"O Straume","year":"2006","unstructured":"Straume O et al (2006) Bevacizumab therapy for POEMS syndrome. Blood 107:4972\u20134973","journal-title":"Blood"},{"key":"9110_CR69","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00277-013-1673-9","volume":"92","author":"V Perfetti","year":"2013","unstructured":"Perfetti V et al (2013) Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome. Ann Hematol 92:1133\u20131134","journal-title":"Ann Hematol"},{"key":"9110_CR70","first-page":"357","volume":"2","author":"J Guitard","year":"2009","unstructured":"Guitard J, Pillet A, Soubrier M, Modesto A, Chauveau D (2009) Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: Insights from sequential VEGF monitoring. NDT Plus 2:357\u2013359","journal-title":"NDT Plus"},{"key":"9110_CR71","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1182\/blood-2005-03-0910","volume":"106","author":"A Badros","year":"2005","unstructured":"Badros A et al (2005) Bevacizumab therapy for POEMS syndrome. Blood 106:1135","journal-title":"Blood"},{"key":"9110_CR72","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/annonc\/mdm602","volume":"19","author":"P-Y Dietrich","year":"2007","unstructured":"Dietrich P-Y, Duchosal MA (2007) Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Ann Oncol 19:595\u2013595","journal-title":"Ann Oncol"},{"key":"9110_CR73","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/bmt.2008.381","volume":"43","author":"C Ohwada","year":"2009","unstructured":"Ohwada C et al (2009) Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transpl 43:739\u2013740","journal-title":"Bone Marrow Transpl"},{"key":"9110_CR74","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ajh.24356","volume":"91","author":"TV Kourelis","year":"2016","unstructured":"Kourelis TV et al (2016) Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience. Am J Hematol 91:585\u2013589","journal-title":"Am J Hematol"},{"key":"9110_CR75","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/leu.2015.344","volume":"30","author":"TV Kourelis","year":"2016","unstructured":"Kourelis TV et al (2016) Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment. Leukemia 30:1079\u20131085","journal-title":"Leukemia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9110-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:11:01Z","timestamp":1574986261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9110-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["9110"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9110-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Both authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}